Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03347786 · ClinicalTrials.gov registry record · Phase 1
Verapamil for Neuroprotection in Stroke
A Phase 1 study of Ischemic Stroke, sponsored by Global Neurosciences Institute.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 60
- Enrollment target
- 3
- Study locations
NCT03347786 is a Phase 1 study of Ischemic Stroke that is actively recruiting participants, run by Global Neurosciences Institute. The registered enrollment target is 60 participants, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (96% lower). The trial reports 3 study locations across 2 states.
The verdict
NCT03347786, a Phase 1 study of Ischemic Stroke, is actively recruiting participants, sponsored by Global Neurosciences Institute.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 60 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), and how it affects recovery from stroke. Recruitment is limited to patients that have received mechanical thrombectomy as standard of care.
Conditions Studied
Interventions
- DRUG 10 mg Intra-arterial Verapamil
- DRUG 20 mg Intra-arterial Verapamil
Study Locations (3)
Pennsylvania
- St Mary Medical Center - Langhorne
- Crozer Chester Medical Center - Upland
New Jersey
- AtlantiCare Regional Medical Center - Atlantic City
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2017-04-20 |
| Est. Completion | 2026-12 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03347786
The ClinicalTrials.gov registry entry for NCT03347786 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,463-participant average among 66 other Ischemic Stroke trials with a reported enrollment target (96% lower). The listed sponsor is Global Neurosciences Institute, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Ischemic Stroke appearing as the primary indexed condition, and to 2 interventions - of which 10 mg Intra-arterial Verapamil is the first listed.
NCT03347786 reports 3 study locations spanning 2 distinct geographic areas - top geographies include Pennsylvania, New Jersey.
Frequently Asked Questions
What is clinical trial NCT03347786 about?
NCT03347786 is a clinical study titled "Verapamil for Neuroprotection in Stroke". The purpose of this research study is to test an experimental procedure called intra-arterial delivery of verapamil in patients diagnosed with acute ischemic stroke. This study investigates the safety of intra-arterial delivery of verapamil, a drug used to treat vasospasm (spasm of a blood vessel), ...
What is the current status of trial NCT03347786?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 60 participants. The study started on 2017-04-20. Estimated completion is 2026-12.
What conditions does trial NCT03347786 study?
This clinical trial studies the following conditions: Ischemic Stroke.
What interventions are being tested in trial NCT03347786?
The interventions under investigation include: 10 mg Intra-arterial Verapamil (DRUG), 20 mg Intra-arterial Verapamil (DRUG).
Who is sponsoring clinical trial NCT03347786?
This trial is sponsored by Global Neurosciences Institute, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03347786 being conducted?
This trial has 3 study locations across New Jersey, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Ischemic Stroke
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability
RECRUITING · Phase 1
-
A Safety and Tolerability Study of Neural Stem Cells (NR1) in Subjects With Chronic Ischemic Subcortical Stroke (ISS)
ACTIVE NOT RECRUITING · Phase 1
-
A Study of NCS-01 in Patients With Acute Ischemic Stroke
ACTIVE NOT RECRUITING · Phase 1
-
Functional Magnetic Resonance Imaging (fMRI) and Robot-Assisted Practice of Activities of Daily Living
COMPLETED · Phase 1
-
The Capillary Index Score Trial
COMPLETED · Phase 1
-
Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients
COMPLETED · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.